These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 4148514)
21. [Metabolism of oxaflumazine]. Boissier JR; Gérardin A; Dumont C Ann Pharm Fr; 1972 Dec; 30(12):851-60. PubMed ID: 4148298 [No Abstract] [Full Text] [Related]
22. Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors. Gobert A; Di Cara B; Cistarelli L; Millan MJ J Pharmacol Exp Ther; 2003 Apr; 305(1):338-46. PubMed ID: 12649387 [TBL] [Abstract][Full Text] [Related]
23. The metabolism of EGYT-475, a new antidepressant agent, in rats. Guttmann A; Nagy J; Magyar K Pol J Pharmacol Pharm; 1987; 39(2):123-8. PubMed ID: 3432157 [TBL] [Abstract][Full Text] [Related]
24. The metabolism of 1-n-butyl-5,5-diethylbarbituric acid (N-n-butyl barbital) in the rat. Vore M; Sweetman BJ; Bush JT J Pharmacol Exp Ther; 1974 Aug; 190(2):384-94. PubMed ID: 4449048 [No Abstract] [Full Text] [Related]
25. [The agonist of dopamine receptors piribedil in treatment of Parkinson's disease]. Pilipovich AA; Golubev VL Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):83-90. PubMed ID: 28745677 [TBL] [Abstract][Full Text] [Related]
26. [Study on metabolism of alpha, alpha-diethyl-3,4-methylenedioxyphenylacetamide (Hoe 264) in guinea pigs]. Volz M Arzneimittelforschung; 1973 Aug; 23(8):1024-7. PubMed ID: 4801019 [No Abstract] [Full Text] [Related]
27. Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease. Perez-Lloret S; Rascol O CNS Drugs; 2016 Aug; 30(8):703-17. PubMed ID: 27344665 [TBL] [Abstract][Full Text] [Related]
28. The metabolism of piperonyl butoxide in the rat with 14C in the methylenedioxy or alpha-methylene group. Fishbein L; Falk HL; Fawkes J; Jordan S; Corbett B J Chromatogr; 1969 Apr; 41(1):61-79. PubMed ID: 5780866 [No Abstract] [Full Text] [Related]
29. [Metabolism of the antidepressant azaphene in rats]. Gortinskaia TV; Siniukhin VN; Ostroumova HG; Rozynov BV; Nyrkova VG Farmakol Toksikol; 1973; 36(5):673-7. PubMed ID: 4802265 [No Abstract] [Full Text] [Related]
30. Piribedil-induced anti-hypoxic protection in rats. Saligaut C; Moore N; Daoust M; Chretien P; Boismare F Aviat Space Environ Med; 1982 Jan; 53(1):35-9. PubMed ID: 7055488 [TBL] [Abstract][Full Text] [Related]
32. The metabolism of phenylbutazone in the rat. Bakke OM; Draffan GH; Davies DS Xenobiotica; 1974 Apr; 4(4):237-54. PubMed ID: 4603132 [No Abstract] [Full Text] [Related]
33. [Piribedil, dopaminergic agonist and the cerebral neurovascular syndrom of the aging man (author's transl)]. Babeau P; Pras P; Serizet A Sem Hop; 1980 Jan 18-25; 56(3-4):188-92. PubMed ID: 6244655 [TBL] [Abstract][Full Text] [Related]
34. Dopaminergic agonist effects on Parkinsonian clinical features and brain monamine metabolism. Rinne UK; Sonninen V; Marttila R Adv Neurol; 1975; 9():383-92. PubMed ID: 1096575 [TBL] [Abstract][Full Text] [Related]
35. [On the metabolism of eprazinone (author's transl)]. Toffel-Nadolny P; Gielsdorf W Arzneimittelforschung; 1981; 31(4):719-22. PubMed ID: 7195719 [TBL] [Abstract][Full Text] [Related]